6.
Lv Z, Qiao L, Wang Q, Piccialli F
. Advanced Machine-Learning Methods for Brain-Computer Interfacing. IEEE/ACM Trans Comput Biol Bioinform. 2020; 18(5):1688-1698.
DOI: 10.1109/TCBB.2020.3010014.
View
7.
Besson F, Fernandez B, Faure S, Mercier O, Seferian A, Blanchet E
. Diffusion-weighted Imaging Voxelwise-matched Analyses of Lung Cancer at 3.0-T PET/MRI: Reverse Phase Encoding Approach for Echo-planar Imaging Distortion Correction. Radiology. 2020; 295(3):692-700.
DOI: 10.1148/radiol.2020192013.
View
8.
Meier-Schroers M, Homsi R, Gieseke J, Schild H, Thomas D
. Lung cancer screening with MRI: Evaluation of MRI for lung cancer screening by comparison of LDCT- and MRI-derived Lung-RADS categories in the first two screening rounds. Eur Radiol. 2018; 29(2):898-905.
DOI: 10.1007/s00330-018-5607-8.
View
9.
Salem A, Little R, Latif A, Featherstone A, Babur M, Peset I
. Oxygen-enhanced MRI Is Feasible, Repeatable, and Detects Radiotherapy-induced Change in Hypoxia in Xenograft Models and in Patients with Non-small Cell Lung Cancer. Clin Cancer Res. 2019; 25(13):3818-3829.
DOI: 10.1158/1078-0432.CCR-18-3932.
View
10.
Tang X, Xu X, Han Z, Bai G, Wang H, Liu Y
. Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer. Biomed Eng Online. 2020; 19(1):5.
PMC: 6975040.
DOI: 10.1186/s12938-019-0744-0.
View
11.
Khalil A, Majlath M, Gounant V, Hess A, Laissy J, Debray M
. Contribution of magnetic resonance imaging in lung cancer imaging. Diagn Interv Imaging. 2016; 97(10):991-1002.
DOI: 10.1016/j.diii.2016.08.015.
View
12.
Allen B, Schiebler M, Sommer G, Kauczor H, Biederer J, Kruser T
. Cost-effectiveness of lung MRI in lung cancer screening. Eur Radiol. 2019; 30(3):1738-1746.
DOI: 10.1007/s00330-019-06453-9.
View
13.
Miles A, Taylor S, Evans R, Halligan S, Beare S, Bridgewater J
. Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment. Eur Radiol. 2019; 29(7):3889-3900.
PMC: 6554244.
DOI: 10.1007/s00330-019-06153-4.
View
14.
Evans R, Taylor S, Beare S, Halligan S, Morton A, Oliver A
. Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations. Br J Radiol. 2018; 91(1086):20170731.
PMC: 6223281.
DOI: 10.1259/bjr.20170731.
View
15.
Taunk N, Oh J, Shukla-Dave A, Beal K, Vachha B, Holodny A
. Early posttreatment assessment of MRI perfusion biomarkers can predict long-term response of lung cancer brain metastases to stereotactic radiosurgery. Neuro Oncol. 2017; 20(4):567-575.
PMC: 5909646.
DOI: 10.1093/neuonc/nox159.
View
16.
Guan X, Yang B, Xie M, Ban D, Zhao X, Lal R
. MRI reporter gene MagA suppresses transferrin receptor and maps Fe dependent lung cancer. Nanomedicine. 2019; 21:102064.
DOI: 10.1016/j.nano.2019.102064.
View
17.
Dahlsgaard-Wallenius S, Hildebrandt M, Johansen A, Vilstrup M, Petersen H, Gerke O
. Hybrid PET/MRI in non-small cell lung cancer (NSCLC) and lung nodules-a literature review. Eur J Nucl Med Mol Imaging. 2020; 48(2):584-591.
DOI: 10.1007/s00259-020-04955-z.
View
18.
Jung W, Park C, Hong C, Suh S, Ahn S
. Diffusion-Weighted Imaging of Brain Metastasis from Lung Cancer: Correlation of MRI Parameters with the Histologic Type and Gene Mutation Status. AJNR Am J Neuroradiol. 2018; 39(2):273-279.
PMC: 7410588.
DOI: 10.3174/ajnr.A5516.
View
19.
Chen L, Zeng X, Wu Y, Yan X, Huang X, Chen H
. A Study of the Correlation of Perfusion Parameters in High-Resolution GRASP MRI With Microvascular Density in Lung Cancer. J Magn Reson Imaging. 2018; 49(4):1186-1194.
DOI: 10.1002/jmri.26340.
View
20.
Meyer M, Budjan J
. Whole-body MRI for lung cancer staging: a step in the right direction. Lancet Respir Med. 2019; 7(6):471-472.
DOI: 10.1016/S2213-2600(19)30081-5.
View